After adjustment for hydroxyurea therapy by analysis of variance, patients with sickle cell disease had higher plasma interleukin-8, interleukin-10, and VEGF concentrations compared to the control participants and lower plasma RANTES concentrations (Table 1). Here, CCL5 is linked to sickle cell disease.